# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Before 10 a.m. ET Friday, 108 stocks made new 52-week highs.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...
Thursday morning saw 23 companies set new 52-week highs.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...
BTIG analyst Sung Ji Nam downgrades GenMark Diagnostics (NASDAQ:GNMK) from Buy to Neutral.
Cowen & Co. analyst Doug Schenkel downgrades GenMark Diagnostics (NASDAQ:GNMK) from Outperform to Market Perform and rai...
Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc (NASDAQ: GNMK) in a
Canaccord Genuity analyst Max Masucci downgrades GenMark Diagnostics (NASDAQ:GNMK) from Buy to Hold.